Nystatin A3

Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.

Cross Reference

Introduction

To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Nystatin A3?

Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Nystatin A3

MeSH term MeSH ID Detail
Anemia, Sickle Cell D000755 34 associated lipids
Aspergillosis D001228 5 associated lipids
Blastomycosis D001759 5 associated lipids
Body Weight D001835 333 associated lipids
Burns D002056 34 associated lipids
Candidiasis, Oral D002180 11 associated lipids
Candidiasis, Vulvovaginal D002181 8 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Dermatomycoses D003881 17 associated lipids
Gonorrhea D006069 7 associated lipids
Hemolysis D006461 131 associated lipids
HIV Seropositivity D006679 15 associated lipids
Hypertension D006973 115 associated lipids
Influenza, Human D007251 11 associated lipids
Leishmaniasis D007896 19 associated lipids
Mycoses D009181 18 associated lipids
Otitis Externa D010032 8 associated lipids
Peritonitis D010538 38 associated lipids
Pregnancy Complications, Infectious D011251 11 associated lipids
Urethritis D014526 9 associated lipids
Vaginitis D014627 6 associated lipids
Xerostomia D014987 6 associated lipids
Vaginosis, Bacterial D016585 10 associated lipids
AIDS-Related Opportunistic Infections D017088 9 associated lipids
Candidemia D058387 2 associated lipids
Per page 10 20 50 | Total 25

PubChem Associated disorders and diseases

What pathways are associated with Nystatin A3

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Nystatin A3?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Nystatin A3?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Nystatin A3?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Nystatin A3?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Nystatin A3?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Nystatin A3

Download all related citations
Per page 10 20 50 100 | Total 1594
Authors Title Published Journal PubMed Link
Ameye D et al. Effect of a buccal bioadhesive nystatin tablet on the lifetime of a Provox silicone tracheoesophageal voice prosthesis. 2005 Acta Otolaryngol. pmid:15966702
Sertié JA et al. Pharmacological assay of Cordia verbenacea V: oral and topical anti-inflammatory activity, analgesic effect and fetus toxicity of a crude leaf extract. 2005 Phytomedicine pmid:15957367
Volokhan O et al. An unexpected role for the putative 4'-phosphopantetheinyl transferase-encoding gene nysF in the regulation of nystatin biosynthesis in Streptomyces noursei ATCC 11455. 2005 FEMS Microbiol. Lett. pmid:15990252
Chan A and Ignoffo RJ Survey of topical oral solutions for the treatment of chemo-induced oral mucositis. 2005 J Oncol Pharm Pract pmid:16595065
Matas AJ et al. Prednisone-free maintenance immunosuppression-a 5-year experience. 2005 Am. J. Transplant. pmid:16162197
Croy SR and Kwon GS Polysorbate 80 and Cremophor EL micelles deaggregate and solubilize nystatin at the core-corona interface. 2005 J Pharm Sci pmid:16200548
Jin Y et al. Characterization of switch phenotypes in Candida albicans biofilms. 2005 Mycopathologia pmid:16205967
Normand S et al. Oral nystatin prophylaxis of Candida spp. colonization in ventilated critically ill patients. 2005 Intensive Care Med pmid:16195905
Eggimann P et al. Oral nystatin as antifungal prophylaxis in critically ill patients: an old SDD tool to be renewed? 2005 Intensive Care Med pmid:16195906
Kumar MS et al. Safety and success of kidney transplantation and concomitant immunosuppression in HIV-positive patients. 2005 Kidney Int. pmid:15780120
Sadashiva MP et al. Enhancement in antimicrobial activity of 2-(phenyl)-3-(2-butyl-4-chloro-1H-imidazolyl)-5-butylate isoxazolidine. 2005 Bioorg. Med. Chem. Lett. pmid:15780612
Ates M et al. The effect of calcium chelating or binding agents on Candida albicans. 2005 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:16243251
Hapala I et al. Two mutants selectively resistant to polyenes reveal distinct mechanisms of antifungal activity by nystatin and amphotericin B. 2005 Biochem. Soc. Trans. pmid:16246082
Sletta H et al. Nystatin biosynthesis and transport: nysH and nysG genes encoding a putative ABC transporter system in Streptomyces noursei ATCC 11455 are required for efficient conversion of 10-deoxynystatin to nystatin. 2005 Antimicrob. Agents Chemother. pmid:16251298
Wandersee NJ et al. Erythrocyte adhesion is modified by alterations in cellular tonicity and volume. 2005 Br. J. Haematol. pmid:16225657
Kuriyama T et al. In vitro susceptibility of oral Candida to seven antifungal agents. 2005 Oral Microbiol. Immunol. pmid:16238594
Chang CT et al. Vasopressin-stimulated CFTR Cl- currents are increased in the renal collecting duct cells of a mouse model of Liddle's syndrome. 2005 J. Physiol. (Lond.) pmid:15513933
Razonable RR et al. Nystatin induces secretion of interleukin (IL)-1beta, IL-8, and tumor necrosis factor alpha by a toll-like receptor-dependent mechanism. 2005 Antimicrob. Agents Chemother. pmid:16048981
Inal J et al. The complement inhibitor, CRIT, undergoes clathrin-dependent endocytosis. 2005 Exp. Cell Res. pmid:16112669
Phillips SM and Dellinger TM Dental decay due to xerostomia and nystatin. 2005 Ann Pharmacother pmid:16118267
Thomas KK et al. Why do different criteria for 'cure' yield different conclusions in comparing two treatments for bacterial vaginosis? 2005 Sex Transm Dis pmid:16118599
Self TJ et al. Clathrin-independent internalization of the human histamine H1-receptor in CHO-K1 cells. 2005 Br. J. Pharmacol. pmid:16086035
Fjaervik E and Zotchev SB Biosynthesis of the polyene macrolide antibiotic nystatin in Streptomyces noursei. 2005 Appl. Microbiol. Biotechnol. pmid:15700127
Chami N et al. Study of anticandidal activity of carvacrol and eugenol in vitro and in vivo. 2005 Oral Microbiol. Immunol. pmid:15720571
Ng AW et al. Liposomal polyene antibiotics. 2005 Meth. Enzymol. pmid:15721388
Papanikolaou A et al. Cholesterol-dependent lipid assemblies regulate the activity of the ecto-nucleotidase CD39. 2005 J. Biol. Chem. pmid:15890655
Ginolhac A et al. Type I polyketide synthases may have evolved through horizontal gene transfer. 2005 J. Mol. Evol. pmid:15909225
Chitarra GS et al. Differentiation inside multicelled macroconidia of Fusarium culmorum during early germination. 2005 Fungal Genet. Biol. pmid:15914044
Skinner N et al. Clinical inquiries. What is angular cheilitis and how is it treated? 2005 J Fam Pract pmid:15865910
Li N et al. The Listeria protein internalin B mimics hepatocyte growth factor-induced receptor trafficking. 2005 Traffic pmid:15882443
Pucadyil TJ et al. The sterol-binding antibiotic nystatin differentially modulates ligand binding of the bovine hippocampal serotonin1A receptor. 2004 Biochem. Biophys. Res. Commun. pmid:15219865
Gallagher R Methadone mouthwash for the management of oral ulcer pain. 2004 J Pain Symptom Manage pmid:15120763
Llabot JM et al. Drug release from carbomer:carbomer sodium salt matrices with potential use as mucoadhesive drug delivery system. 2004 Int J Pharm pmid:15113614
Rodighiero S et al. The voltage-dependent nonselective cation current in human red blood cells studied by means of whole-cell and nystatin-perforated patch-clamp techniques. 2004 Biochim. Biophys. Acta pmid:14757232
Crandall M The pathogenetic significance of intestinal Candida colonization. 2004 Int J Hyg Environ Health pmid:14762978
Coutinho A et al. Cholesterol and ergosterol influence nystatin surface aggregation: relation to pore formation. 2004 Biophys. J. pmid:15315952
Sanchez S et al. Intravaginal metronidazole gel versus metronidazole plus nystatin ovules for bacterial vaginosis: a randomized controlled trial. 2004 Am. J. Obstet. Gynecol. pmid:15592270
Buzzini P et al. First large-scale isolation of Prototheca zopfii from milk produced by dairy herds in Italy. 2004 Mycopathologia pmid:15630551
Scullion FT and Scullion MG Successful treatment of megabacteriosis in a canary (Serinus canaria) with nystatin. 2004 Vet. Rec. pmid:15551929
Khan MA et al. Prophylactic role of immunomodulators in treatment of systemic candidiasis in leukopenic mice. 2004 J Drug Target pmid:15621667
Offner F et al. Liposomal nystatin in patients with invasive aspergillosis refractory to or intolerant of amphotericin B. 2004 Antimicrob. Agents Chemother. pmid:15561860
Delmas D et al. Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells. 2004 Oncogene pmid:15480430
Vijayvargia R et al. Functional form of Caveolin-1 is necessary for the assembly of alpha-hemolysin. 2004 Biochem. Biophys. Res. Commun. pmid:15485672
Hull C and von Gersdorff H Fast endocytosis is inhibited by GABA-mediated chloride influx at a presynaptic terminal. 2004 Neuron pmid:15504327
Oliver RJ et al. Patterns of antifungal prescribing in general dental practice. 2004 Br Dent J pmid:15192736
Bruheim P et al. Chemical diversity of polyene macrolides produced by Streptomyces noursei ATCC 11455 and recombinant strain ERD44 with genetically altered polyketide synthase NysC. 2004 Antimicrob. Agents Chemother. pmid:15504830
Meyer zum Bueschenfelde CO et al. Regulated recruitment of MHC class II and costimulatory molecules to lipid rafts in dendritic cells. 2004 J. Immunol. pmid:15528348
Fortin DL et al. Lipid rafts mediate the synaptic localization of alpha-synuclein. 2004 J. Neurosci. pmid:15282274
Aksungur P et al. Chitosan delivery systems for the treatment of oral mucositis: in vitro and in vivo studies. 2004 J Control Release pmid:15262418
Triantafilou K and Triantafilou M Lipid-raft-dependent Coxsackievirus B4 internalization and rapid targeting to the Golgi. 2004 Virology pmid:15262490